Mitochondrial dynamics, including mitochondrial division, fusion and transport, are integral parts of mitochondrial and cellular function. DNM1L encodes dynamin-related protein 1 (Drp1), a member of the dynamin-related protein family that is required for mitochondrial division. Several de novo mutations in DNM1L are associated with a range of disease states. Here we report the identification of five patients with pathogenic or likely pathogenic variants of DNM1L, including two novel variants. Interestingly, all of the positions identified in these Drp1 variants are fully conserved among all members of the dynamin-related protein family that are involved in membrane division and organelle division events. This work builds upon and expands the clinical spectrum associated with Drp1 variants in patients and their impact on mitochondrial division in model cells.
Introduction
Mitochondrial function is essential for many cellular processes. In addition to their canonical role in energy production and metabolism, mitochondria also contribute to lipid biosynthesis, iron cluster formation and other cellular pathways including autophagy, inflammasome activation, telomere maintenance and apoptotic cell death (1, 2) . Mitochondria exist as a complex and dynamic network that moves, fuses and divides (3, 4) . These processes are mediated by conserved protein families and are essential for mitochondrial distribution and quality control.
Mitochondrial division requires the coordinated action of several factors. The actin cytoskeleton and endoplasmic reticulum both contribute early in the process of division, cooperating to constrict the diameter of mitochondria (5, 6) . Further constriction of mitochondria is driven by dynamin-related protein 1 (Drp1), a mechanochemical enzyme encoded by the DNM1L gene (7) . The protein is found in the cytosol and is recruited to mitochondria by protein receptors embedded in the mitochondrial outer membrane. There are several different receptors including Mff, Fis1, MiD49 and MiD51 (5) . The functional role of each receptor is not clear, but there is evidence to suggest that they can work both cooperatively and independently (8) (9) (10) (11) . Drp1 assembly is mediated by the stalk domain, which forms a helical bundle that extends from the globular GTPase domain and has multiple interaction surfaces ( Fig. 1) (12, 13) . In the cytosol, Drp1 is a dimer and recruitment to mitochondria by receptors stimulates higher-order assembly of Drp1. Following assembly of a Drp1 ring or helix on the mitochondrial surface, guanosine trinucleotide phosphate (GTP) binding and hydrolysis drive conformational changes that are coupled to constriction and disassembly (14, 15) . The final step of mitochondrial division in vertebrates requires a related enzyme, dynamin-2, which works by a mechanism similar to Drp1 and constricts the mitochondria to the very narrow diameter required for separation of membranes (16) . Interestingly, many components of the mitochondrial division machine have also been shown to be required for division of peroxisomes (17, 18) .
Perturbations in mitochondrial division affect cell and organism health. Impaired mitochondrial fusion results in fragmentation of the mitochondrial network, due to ongoing division (19) . In contrast, loss of division results in unopposed fusion, causing excessive extension of tubules and interconnection of the network (20) . In both cases, mitochondrial distribution and function are compromised. Indeed, loss of Drp1 is embryonic lethal in mice and tissue-specific knockout in the cerebellum is catastrophic, resulting in death within one day of birth (21, 22) .
Several heterozygous de novo missense mutations in DNM1L have been reported in humans (MIM #614388 and 610708). All lethal variants reported thus far are found in the stalk domain (23) (24) (25) . These patients all presented with central nervous system dysgenesis and neurodegeneration manifesting as hypotonia, developmental regression and an abnormal magnetic resonance imaging (MRI) of the brain. Some pathological variants in the stalk domain of Drp1 support life, but present with seizures and developmental delay. For example, a variant in the stalk domain (G362D) was identified in a patient who presented with global developmental delay at six months of age and refractory epilepsy at one year (26) . Another variant within the stalk domain (R403C) was reported in two unrelated individuals who presented with later onset refractory epilepsy, encephalopathy, developmental regression and myoclonus (27) . There are also reports of mutations in the GTPase domain that cause autosomal dominant optic atrophy (E2A and A192E) or hypotonia and developmental delay (T115M) (28, 29) . The dominant inheritance pattern and the molecular characterization of a few mutant variants together suggest that disease variants have limited protein function and also interfere with the function of wild-type Drp1 in heterozygous patients, likely through heterotypic complex formation (27, 30) .
Here we describe five patients with mutations in DNM1L. We report two novel de novo heterozygous missense mutations, one in the stalk that is lethal (C431Y) and one in the GTPase domain (G32A). In addition, two patients were identified with a pathogenic variant that has been previously reported (R403C). Finally, we report a more modest impact for a missense variant at position A395, compatible with survival (A395G), in contrast to the lethal variant that introduces a charge at that position (A395D). We have also performed functional characterization of each variant to gain insight into the pathophysiology of diseases associated with Drp1 variants. Our data suggests that different variants have unique molecular profiles that lead to a variety of disease states.
Results

Clinical phenotypes of individuals with pathogenic variants in DNML1 varied significantly between genotypes
All five individuals presented with hypotonia and developmental delays and/or regression. The degree of cognitive delay varied among individuals. Half of the individuals were documented to have seizures, but only the individual with the G32A variant exhibited significant ocular involvement. Brain MRI abnormalities and biochemical markers including lactate and very long chain fatty acids were variably abnormal (Table 1 and Supplementary Material). In fibroblast cells, the mitochondrial network is composed of many tubular organelles distributed throughout the cell. Loss of division activity by deletion or mutation of Drp1 results in dramatic mitochondrial elongation and interconnection due to unopposed mitochondrial fusion (7, 21, 22) . To determine if the novel mutation identified in Patient 4 (G32A) altered mitochondrial structure, we visualized mitochondria in patient-derived primary fibroblasts. Indeed, we observed a highly connected mitochondrial network in the patient cells compared to agematched control fibroblasts ( Fig. 2A and B ). Many regions of the network formed net-like structures that are characteristic of defective Drp1 function and loss of mitochondrial division ( Fig. 2A, inset ). Drp1 has also been implicated in peroxisome division and abundance (31) . Peroxisome biosynthesis includes elongation of the organelle, which is followed by Drp1-mediated division. Two reported variants in the stalk of Drp1, G362D and A395D, cause peroxisome elongation in patient fibroblasts, consistent with reduced division activity (23, 26) . To determine if Drp1-G32A similarly affects peroxisome morphology, we visualized peroxisomes in fibroblasts from Patient 4 and the age-matched control. The observed peroxisome length and number were indistinguishable between control and patient cells, indicating that peroxisome division is not notably altered in the patient fibroblasts (Supplementary Material, Fig. S1 ).
Drp1 mutant alleles cannot restore normal mitochondrial morphology in Drp1 null cells
To determine how the identified DNM1L mutations affected Drp1-mediated mitochondrial division, we assessed the ability of each mutant to rescue the mitochondrial morphology defect in cells lacking Drp1. HCT116 cells lacking Drp1 (Drp1 -/-) have an extensively interconnected mitochondrial network ( Fig. 3A , empty) (32) . Expression of human Drp1 in Drp1 -/-cells resulted in the restoration of some shorter mitochondrial tubules (Fig. 3A , wild type (WT)). As controls for Drp1 function, we also included two well-characterized mutants that do not support mitochondrial division, Drp1-K38A and Drp1-G350D, throughout our analysis. Drp1-K38A abolishes GTPase activity by changing a key catalytic residue in the P-loop, which forms the GTP-binding pocket (33) . Drp1-G350D is a variant in the stalk domain similar to a previously reported lethal mutation (G350R) and a wellcharacterized mutation in the yeast division protein, Dnm1 (G385D), which interferes with higher-order self-assembly (24, 34, 35) . As expected, in Drp1 null cells expressing Drp1-K38A or Drp1-G350D, mitochondria remained extensively hyperfused, indicating no Drp1-dependent mitochondrial division ( Fig. 3A and B). Similar to Drp1-K38A, Drp1-G32A changes a conserved residue in the nucleotide-binding domain of Drp1. Mitochondria in Drp1
-/-cells expressing Drp1-G32A remained hyperfused, as in Drp1-K38A-expressing cells ( Fig. 3A and B). Drp1 -/-cells expressing Drp1-R403C and Drp1-C431Y also showed no rescue, with hyperfused mitochondria in >95% of cells ( Fig. 3A and B). Consistent with previously reported data, the Drp1-R403C variant was similarly unable to restore wild-type mitochondria morphology in Drp1-null cells ( Fig. 3A and B) (27) . Interestingly, ∼75% of cells expressing Drp1-A395G had mitochondria with a reticular morphology, similar to wild-type cells. This suggests that Drp1-A395G mutant is a hypomorph and can support mitochondrial division when overexpressed. These variants are at positions that are fully conserved in the members of the dynamin-related protein family that mediate membrane scission events, consistent with critical function. To explore the impact on conserved function, we characterized the variants in Dnm1, the Saccharomyces cerevisiae mitochondrial division machine. While Drp1 and Dnm1 are very similar, Drp1 cannot restore division in yeast, consistent with unique mechanisms in each organism (11) . To determine if the de novo patient mutations alter a fundamental and conserved property intrinsic to the division activity of Drp1 and separate from its regulation or interaction with other proteins, we made the analogous mutations in yeast dnm1 and expressed these in dnm1 cells to assess Dnm1-mediated mitochondrial division activity. In wild-type yeast, mitochondria are localized to the cell cortex in an extended, branched network (Fig. 4, branched) . In contrast, mitochondria in yeast cells lacking Dnm1 form a netlike structure (Fig. 4, hyperfused) . Expression of wild-type Dnm1-green fluorescent protein (GFP) resulted in a more branched network compared to dnm1 yeast, consistent with restoration of mitochondrial division. Dnm1-K41A (Drp1 K38A) and Dnm1-G385D (Drp1-G350D) expression in Δdnm1 yeast did not change the mitochondrial network compared to empty vector controls, consistent with their characterization as non-functional variants (34, 36) .
As we observed with the human Drp1 mutants, none of the mutations in yeast Dnm1 fully rescued mitochondrial division activity (Fig. 4, Supplementary Material, Fig. S2 ). Dnm1-G35A (Drp1-G32A) exhibited the most severe phenotype, with virtually no branched networks, consistent with no division activity. Drp1 stalk domain mutants, Dnm1-A430G (Drp1-A395G) and Dnm1-C466Y (Drp1-C431Y), each showed moderate rescue of division activity in dnm1 yeast, although not as much as wild-type Dnm1. In contrast, cells expressing Dnm1-R438C (Drp1 R403C) had almost no branched mitochondrial networks, indicating that the R403C mutation also disrupts a conserved function of the mitochondrial division machine.
The dominant-negative effects on mitochondrial division by Drp1 variants
Given that the mutations were heterozygous in patients, we set out to assess whether our identified mutant alleles exert a dominant negative effect, which would interfere with the function of the wild-type Drp1. Indeed, the extensive mitochondrial hyperfusion observed in Patient 4 fibroblasts suggests that the G32A allele is dominant-negative (Fig. 2) . Previous work indicates that overexpression of Drp1-A395D and Drp1-R403C mutants in wild-type cells inhibits normal division activity (27, 30) . We expressed Drp1-GFP mutants by transient transfection with a fluorescent mitochondrial matrix marker in wild-type HCT116 cells, which have normal mitochondrial division activity, and scored mitochondrial morphology. We also examined Drp1-GFP assembly and subcellular localization as a proxy for mitochondrial recruitment and higher-order assembly.
Cells expressing the mitochondrial matrix marker alone or wild-type GFP-Drp1 maintained a reticular mitochondrial network and we observed localization of several GFP-Drp1 foci on mitochondria (Fig. 5) . Expression of either GFP-Drp1-K38A or GFP-Drp1-G350D resulted in a hyperfused mitochondrial network, as expected for dominant negative mutants (Fig. 5,  hyperfused) . GFP-Drp1-K38A formed foci on mitochondria while GFP-Drp1-G350D remained completely cytosolic. These data indicate that, while both block activity of the Drp1-WT, these mutations affect different steps in the division pathway, including recruitment to mitochondria and higher-order Drp1 assembly. GFP-Drp1-G32A also had very strong dominant nega- tive effects, increasing the amount of hyperfused mitochondria from 18.5% in cells expressing Drp1-WT to 86.2% in cells expressing the mutant (Fig. 5A and B) . In contrast to GFP-Drp1-K38A, which forms some foci in cells, GFP-Drp1-G32A remained completely cytosolic, and formed no foci on mitochondria. This indicates that GFP-Drp1-G32A has defects in mitochondrial localization and higher-order assembly. GFP-Drp1-A395G and GFP-Drp1-C431Y had a less severe impact on Drp1-WT function, averaging a 1.9-fold increase in the number of cells with hyperfused mitochondria compared to cells expressing GFP-Drp1-WT or the mitochondrial matrix marker alone ( Fig. 5A and B) . Consistent with this, these mutants show minor defects in mitochondrial recruitment and higher-order assembly in the presence of wild-type Drp1, as all cells expressing these variants show some GFP-Drp1 foci colocalized with mitochondria. Of the stalk domain variants, GFP-Drp1-R403C had stronger dominant negative effects, but GFP-Drp1 recruitment was indistinguishable from the wild-type GFP-Drp1 (Fig. 5A and B) .
To determine if the dominant negative properties of these mutants are conserved, we expressed Dnm1 in wild-type (W303) yeast. Mitochondria in wild-type yeast cells expressing Dnm1 are mostly reticular and branched. In contrast, expression of Dnm1-K41A (Drp1-K38A) or Dnm1-G385D (Drp1-G350D) resulted in mitochondria that are highly connected or hyperfused (Fig. 6 , Supplementary Material, Fig. S3 ). Once again, Dnm1-G35A (Drp1-G32A) was the most potent dominant negative allele from this group of patient variants, with 75% of cells having hyperfused mitochondria compared to 10% with Dnm1-WT (Fig. 6) . In contrast, the stalk domain mutants were only mildly dominant negative, and shifted the population of cells with hyperfused mitochondria from 12% with expression of Dnm1-WT to 15-30% with the mutant proteins (Fig. 6) .
Together, these data indicate that all mutant alleles are loss of function, as they cannot fully restore mitochondrial division activity in cells lacking Drp1/Dnm1. Further, Drp1-G32A and Drp1-R403C both demonstrate a robust dominant negative phenotype, indicating that the mutants interfere with the function of the wild-type protein. In these model cells, the A395G and C431Y variants are partially dominant negative by comparison.
Drp1 mutant alleles interact with wild-type Drp1
The dominant negative activity of Drp1/Dnm1 variants suggests that the mutant Drp1 interacts with wild-type Drp1 to inhibit normal division activity. To test this, we assessed direct interactions of the mutants with wild-type Drp1 using a yeast twohybrid assay. Wild-type Drp1 interacts with itself, as indicated by growth of cells expressing activating domain (AD)-Drp1 and binding domain (BD)-Drp1 (Fig. 7) . Drp1-G350D and Drp1-A395D did not interact with Drp1-WT in this assay, consistent with previously published data (30, 37) . Given the strong inhibition of Drp1 activity in wild-type cells upon expression of these mutants, these data indicate that the yeast two-hybrid does not detect the interaction interface that allows these mutants to assemble with wild-type protein. In contrast, Drp1-K38A and all of the de novo mutants described here interact with Drp1-WT, consistent with dominant negative effects.
Discussion
Mitochondria are complex and dynamic organelles, constantly changing their overall structure and organization through the coordination of mitochondrial division, fusion and transport. Genetic models that abolish genes encoding proteins required for mitochondrial dynamics illustrate that these activities are required for normal development (21, 22) . Furthermore, mutations in DNM1L have been reported in patients causing a range of disease states including early lethality, seizures, developmental delay and dominant optic atrophy. Given the spectrum of observed disease outcomes in affected individuals, it is important to fully characterize new disease-associated alleles, to address the dearth in our knowledge of how changes in Drp1 function alter physiology. In this particular condition, this information is of paramount importance for accurate interpretation of DNM1L variants and diagnosis, given the paucity of characteristic and consistent clinical and/or biochemical markers of DNM1L-related disease.
Herein, we report the identification of five patients with pathogenic or likely pathogenic variants mutations in the DNM1L gene, including a novel lethal variant in the stalk domain (C431Y; Patient 1), a previously reported variant (R403C; Patients 2 and 3), a novel missense variant in the GTPase domain (G32A; Patient 4) and a novel missense variant at a previously reported residue (A395G; Patient 5).
All of these variants are of highly conserved amino acids within the dynamin family and were not observed in the general public databases (genome aggregation database (gnomAD), Exome Sequencing Project). In silico analysis (Provean, MutTaster, SIFTnew, CADD, PhyloP, PolyPhen-2) predicts that all of these variants are probably damaging to the protein structure/function. To further investigate the functional consequences of these variants, we performed a molecular analysis for their effects upon mitochondrial division in vertebrates and S. cerevisiae. The analysis in each model system was internally consistent, indicating that the highly conserved function of the mitochondrial division machine was altered, rather than regulatory pathways or interactions with other proteins. Interestingly, not all alleles exhibit the same strong dominant negative phenotype in the model systems tested here, unlike previously reported disease alleles (27, 30) . The fact that the variants with partial dominant negative activity do not restore mitochondrial division in cells lacking Drp1 or Dnm1 raises the possibility that the pathophysiology of these diseases includes haploinsufficiency. However, we cannot exclude that the model systems do not fully recapitulate the complexity of human tissues affected in these patients.
Interestingly, our molecular analysis of Drp1-C431Y is discordant with the early death of Patient 1, as the allele is null, but is not the most robust dominant negative activity in the HCT116 and S. cerevisiae cells tested here. This suggests that the defect caused by Drp1-C431Y is minimized in these models but is catastrophic in the context of a specialized cell or tissue type, such as post mitotic neurons. Of significance, this position maps to an assembly interface identified in the crystal structure of Drp1. Other variants in this region (E426A and R430D) were characterized in vitro and were indistinguishable from Drp1-WT in their ability to self-assemble, interact with liposomes and hydrolyze GTP (13) . In contrast, these mutants did not tubulate liposomes in vitro, indicative of a defect in the formation of stable, membrane-anchored assemblies that can constrict mitochondria. While C431 is not implicated in the formation of intramolecular bonds as E426 and E430 are, the mutation to tyrosine could alter the integrity of the interface and impact assembly.
Consistent with previous reports, Patients 2 and 3 (R403C) both presented with seizures and developmental regression. Our functional characterization of Drp1-R403C demonstrates that this mutant cannot support mitochondrial division and is dominant negative (27) . Interestingly, this position falls within a highly conserved loop in the dynamin family. One very well characterized mutation in dynamin also falls in this loop and completely abrogates assembly (38) .
In both vertebrate cells and in S. cerevisiae, Drp1-G32A had the most robust dominant negative phenotype. The complete lack of GFP foci in cells is consistent with an inability to assembly into higher-order structures and there is no apparent recruitment to mitochondria. Patient 4 also presented with optic atrophy. Autosomal dominant optic atrophy was previously reported in patients identified with de novo variants in the GTPase domain of Drp1 (28), suggesting that the functional defects associated with variants in this region are distinctly detrimental in this tissue, specifically at the level of ganglion cells. Additionally, this patient was shown to have pure progressive sensory neuropathy, which is likely a major contributor to her ataxia. To our knowledge, pure sensory neuropathy has not been reported previously in DNM1L associated disorders although findings attributable to an underlying neuropathy including ataxia, absent deep tendon reflexes and pain insensitivity have been reported (39) . However, sensory neuropathy is well documented in a known mitochondrial fission defect causing Charcot-Marie-Tooth syndrome (40) .
The first report of a disease-associated mutation in DNM1L was a lethal variant, Drp1-A395D. This is a dramatic alteration, from a small and neutral amino acid to a large, branched and charged residue. Drp1-A395D was dominant negative in cells and was predicted to disrupt the assembly of Drp1 required for mitochondrial division (30) . In contrast, we report a relatively modest change (alanine to glycine) that has a more modest impact on Drp1 function. These data reveal that, while this site is sensitive to changes, the overall impact on Drp1 function can be grossly different dependent on the exact electrophysiological characteristics of the precise amino acid substitution.
Materials and Methods
Research subjects
The guardians of the individuals participating in this study gave written, informed consent through journal publication consents or as part of clinical protocols or waivers approved by the Institutional Review Boards of the respective home institutions. Deoxyribonucleic acid (DNA) was harvested from peripheral whole blood. Fibroblast cultures were established from forearm full thickness skin punch biopsies or quadriceps muscle biopsies obtained for diagnostic purposes. Mitochondrial respiratory chain analysis, when performed, occurred in a clinical laboratory using previously described methods (41, 42) .
Whole exome sequencing
Clinical whole exome sequencing (WES) testing was performed for all patients and their parents as described (43) . A trio-based design was utilized for WES. Genomic DNA from either whole blood or fibroblasts was extracted and isolated from the affected proband and the probands' parents using standard methods. DNA libraries were generated using the SureSelect Human All Exon V4 or Clinical Research Exome kit (Agilent Technologies, Santa Clara, California, USA). Data were mapped to the NCBI hg19/GRCh37 human genome reference sequence and analyzed using GeneDx's XomeAnalyzer, an interface for variant annotation, filtering and viewing. The mean depth coverage for the DNM1L gene was 96x, and 100% of the coding region and the adjacent intronic regions were covered at ≥10x. Variants identified by WES were evaluated and classified according to published guidelines (44) . Whole mitochondrial genome sequencing analysis in DNA extracted from whole blood was performed for patients 3-5; mitochondrial DNA sequence was assembled and analyzed relative to the revised Cambridge Reference Sequence and MITOMAP database (http://www.mitomap.org) in combination with concurrent matrilineal relative testing. Identified sequence changes of interest were confirmed via Sanger sequencing, and segregation analysis was performed for family members.
Plasmids and Strains
pcDNA3.1 GFP-Drp1-splice varient 3 (SV3) (7) and pHS20 Dnm1-GFP (45) were used to transfect mammalian and yeast cells, respectively. To construct yeast-two-hybrid plasmids, SV3 of human dynamin-like protein (699 amino acids, NCBI NP_005681.2) was inserted into pGBKT7 and pGADT7 plasmids. Drp1 SV3 was PCR amplified (forward primer -5 -CGCGGAT CCATGGAGGCGCTAATTCCTGTC-3 and reverse primer -5 -ACGCGTCGACTCACCAAAGATGAGTCTCCCGGA-3 ) and inserted into pGAD-C1 using BamHI/SalI sites. Drp1 SV3 was then excised from pGAD-C1 using EcoRI/SalI sites and inserted into pGBKT7 using EcoRI/SalI sites and pGADT7 using EcoRI/XhoI sites. Drp1 mutations were introduced by overlapping PCR mutagenesis with Gibson assembly. To generate mutants for yeast transformation, site-directed mutagenesis PCR of pHS20 Dnm1-GFP was followed by yeast-mediated assembly. Specifically, yeast were transformed with PCR products encoding both halves of the target plasmid with overlapping ends and incubated at 30
• C 
Yeast two-hybrid
Drp1-SV3 pGADT7 variants (prey) were cotransformed with WT-Drp1 pGBKT7 (bait) into PJ64-4A yeast. Transformants were selected on plates lacking leucine and tryptophan. Serial dilutions of yeast were plated on leucine, tryptophan, histidine and adenine deficient plates to assess protein-protein interactions at 30
• C for 2 days. Each experiment was repeated three times. Cells expressing similar levels of Drp1-GFP protein were chosen to score mitochondrial morphology (GFP pixel intensity between 9000 and 15 000 units). Wild-type HCT116 cells were plated at 4 × 10 5 cells per dish. The following day, 50 ng mitochondrial matrix targeted dsRed (mitoRed) and 300 ng Drp1-GFP were transfected with Lipofectamine 2000, according to manufacturer's instructions. Wild-type HCT116 were imaged 16-24 h post-transfection at 37
Cell culture
• C with 5% CO 2 . A Z-series with a step size of 0.3 μm was collected with a Nikon Ti-E widefield microscope with a 63X numerical aperture (NA) 1.4 oil objective (Nikon), a solid-state light source (Spectra X, Lumencor) and a scientific CMOS camera (Zyla 5.5 Megapixel). Each mutant was transfected and imaged on at least three separate occasions (n > 100 cells per experiment). Single colony yeast transformants were grown overnight at 30
• C in synthetic complete media-Leu-Ura + 2% w/v dextrose to mid-log phase. Yeast cells were sonicated (Fisher Sonic Dismembrator Model 100) at setting 1 for 1 s to separate progeny and recovered at least 1 h at 30
• C before imaging. Cells were concentrated by centrifugation and mounted on a 3% low melt agarose pad. All yeast cells were imaged at room temperature using 100x/1.2 oil objective with 1.5X magnification. Three independent yeast clones from two separate transformations were imaged.
Image analysis
Images were deconvolved using eight iterations of 3D Landweber or 3D blind deconvolution (Nikon). Deconvolved images were analyzed using Nikon Elements software. Maximum intensity projections were created using ImageJ Software (NIH). Mitochondrial morphology in mammalian cells was scored as follows:
hyperfused indicates that the entire mitochondrial network was highly connected, with few mitochondrial tips and lacking any mitochondrial fragments (defined as mitochondria less than 2 μm in length); reticular indicates that fewer than 30% of the mitochondria were fragments; fragmented indicates that more than 30% of the mitochondria were less than 2 μm in length. Yeast mitochondria were categorized as hyperfused, branched or fragmented as follows: hyperfused mitochondria included single, elongated tubes and net structures; branched mitochondria indicate a multinodal connected network distributed throughout the cell with >2 mitochondria tips; and fragmented mitochondria were disconnected in short puncta of 0.5 μm or less.
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